Vue transversale de la maladie
Myopathies
Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.
Périmètre
Filtrer toute la vue
Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.
1012 résultats correspondants
· 46 visibles sur cette page
dans le périmètre Myopathies
Niveau clinique
Études et traitements 421
Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Semaglutide (Rybelsus®) NCT07642635 · Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individ… | Myopathies | Traitement symptomatique | Phase 1/2 | NOT_YET_RECRUITING | Duchenne Muscular Dystrophy (DMD) is a rare, genetic disease that leads to… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:44 | Détail |
| Skeletal muscle biopsy (residual specimen) NCT06101940 · Chinese Multicenter Clinical Outcome Cohort Study of Myotonic Dystrophy Type 1 (… | Myopathies | Ralentissement de la progression | À vérifier | ENROLLING_BY_INVITATION | Myotonic dystrophy type 1 (DM1) is an autosomal dominant multisystem disor… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:44 | Détail |
| TODDLER — A Remote Study Using Technology to Assess Outcomes in DMD NCT07423026 · NCT07423026 | Myopathies | À vérifier | À vérifier | RECRUITING | Every year, 100 boys are born in the UK with a rare muscle disease called… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:44 | Détail |
| Adult and Juvenile Myositis NCT00017914 · NCT00017914 | Myopathies | Ralentissement de la progression · Immunomodulation · Traitement symptomatique… | À vérifier | RECRUITING | This study will evaluate subjects with adult- and childhood-onset myositis… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| Botulinum toxin type A NCT05720065 · Peripheral TMD Pain Mechanisms and the Effect by Botulinum Toxin A | Myopathies | Traitement symptomatique | Phase 2 | RECRUITING | The main purpose of this study is to determine which is the best dose of a… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| CovExc — Muscular Rehabilitation by Eccentric Exercise After Severe C… NCT04649086 · NCT04649086 | Myopathies | À vérifier | Non applicable | TERMINATED | With the COVID-19 pandemic, the number of patients to be treated in rehabi… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| Effectiveness of Conservative Interventions in the Treatment of Trigg… NCT06296017 · NCT06296017 | Myopathies | À vérifier | Non applicable | RECRUITING | There is no study in the literature comparing the effectiveness of ESWT an… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| Electrophysiological measurement of reflex nociceptive flexion thresh… NCT04624581 · FIbromyalgia anD GenetIcs Subgroups (FIDGIS) | Myopathies | Traitement symptomatique | Non applicable | COMPLETED | Fibromyalgia syndrome (FS) is characterized by widespread pain and affect… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| Fascial Distortion Model NCT06627855 · Effectiveness of the Fascial Distortion Model in Temporomandibular Disorders: A… | Myopathies | Ralentissement de la progression · Traitement symptomatique | Non applicable | RECRUITING | The aim of the study was to investigate the effectiveness of Manual Therap… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| Intravenously administered pooled human immunoglobulin (IVIG) NCT06599697 · The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Med… | Myopathies | À vérifier | Phase 2 | RECRUITING | This is a randomized, placebo-controlled, double blinded phase 2 explorato… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| LOLA — Effectiveness of Health Education Program on Musculoskeletal P… NCT07160478 · NCT07160478 | Myopathies | Traitement symptomatique | Non applicable | COMPLETED | Musculoskeletal pain during childhood can negatively affect school attenda… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| Prospective, Longitudinal, Observational Registry of Adult Patients W… NCT05596539 · NCT05596539 | Myopathies | À vérifier | À vérifier | RECRUITING | The purpose of this study is to assess medical events during follow-up of… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| Real radial extracorporeal shock wave therapy (rESWT) NCT07476690 · CP-rESWT-FREQ — Effect of rESWT Session Frequency on Spasticity and Function Ass… | Myopathies | Traitement symptomatique | Non applicable | COMPLETED | Spasticity is a major contributor to functional limitations in children wi… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| SeMAFor — Magnesium, Stress and Fibromyalgia NCT03887000 · NCT03887000 | Myopathies | Traitement symptomatique | Non applicable | COMPLETED | Fibromyalgia affects an average of 2% of the French population. Data from… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:43 | Détail |
| AZD5492 NCT06916806 · TITAN — A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharm… | Lupus | Immunomodulation | Phase 1 | RECRUITING | The purpose of this study is to measure the safety, tolerability, PK, and… À vérifier | ClinicalTrials.gov 2026-08-16 21:21:41 | Détail |
| AOC 1020 NCT05747924 · FORTITUDE — Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral… | Myopathies | À vérifier | Phase 1/2 | COMPLETED | A Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluat… À vérifier | ClinicalTrials.gov 2026-08-16 19:04:32 | Détail |
| BMN 351 NCT06280209 · A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Phar… | Myopathies | À vérifier | Phase 1/2 | ACTIVE_NOT_RECRUITING | This open-label extension study aims to evaluate the long-term safety and… À vérifier | ClinicalTrials.gov 2026-08-16 19:04:32 | Détail |
| EPI-321 NCT06907875 · FSHD — A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrop… | Myopathies | Thérapie génique | Phase 1/2 | ACTIVE_NOT_RECRUITING | The goal of this clinical trial is to learn how safe and tolerable EPI-321… À vérifier | ClinicalTrials.gov 2026-08-16 19:04:32 | Détail |
| GNR-097 NCT07673809 · A Study to Evaluate the Tolerability, Safety and Efficacy of GNR-097 Gene Therap… | Myopathies | Thérapie génique | Phase 1/2 | RECRUITING | The study will evaluate the tolerability, safety and efficacy of gene ther… À vérifier | ClinicalTrials.gov 2026-08-16 19:04:32 | Détail |
| PBGENE-DMD (IV) NCT07429240 · PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular… | Myopathies | À vérifier | Phase 1/2 | RECRUITING | The purpose of this Phase 1/2a trial is to evaluate the safety, tolerabili… À vérifier | ClinicalTrials.gov 2026-08-16 19:04:32 | Détail |
Découverte scientifique
Recherches et trouvailles 0
Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Aucune trouvaille ne correspond aux filtres. | |||||||
Bibliographie
Publications 585
Références bibliographiques de la base locale et accès à leur source originale.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Hyaluronic acid nanoparticle as drug delivery carrier for the treatme… Diclofenac 1% Topical · PMID 42578876 | Myopathies | Immunomodulation | Publication | PubMed | Voir la publication source BackgroundAllergic conjunctivitis is an inflammatory disorder of the conjunctiva triggered by allergens. Although topic… | Bio-medical materials and engineering 2026-08-13 15:01:42 | Source |
| Successful Management of Refractory Cannabinoid Hyperemesis Syndrome… Capsaicin Topical Cream · PMID 42491286 | Myopathies | Traitement symptomatique | Publication | PubMed | Voir la publication source Cannabinoid hyperemesis syndrome (CHS) is a debilitating disorder of chronic, heavy cannabis users characterized by cyc… | Clinical medicine insights. Case reports 2026-08-13 15:01:41 | Source |
| Fat Embolism Syndrome Following Elective Orthopedic Surgery in a Pati… Chronic Corticosteroid Therapy · PMID 42572732 | Myopathies | Immunomodulation | Publication | PubMed | Voir la publication source Duchenne muscular dystrophy (DMD) is associated with substantial perioperative morbidity due to progressive cardiopulmo… | Cureus 2026-08-13 15:01:38 | Source |
| Recalibrating Therapeutic Priorities for Duchenne Muscular Dystrophy:… Ataluren · PMID 42510866 | Myopathies | Thérapie génique | Publication | PubMed | Voir la publication source Duchenne muscular dystrophy (DMD) has, for the first time, several mutation-specific drugs in clinical use. Four exon-s… | Genes 2026-08-13 15:01:37 | Source |
| Modular intramedullary knee arthrodesis for chronic periprosthetic jo… Limb salvage · PMID 42585983 | Myopathies | Thérapie génique | Publication | PubMed | Voir la publication source Chronic periprosthetic joint infection (PJI) after total knee arthroplasty (TKA) is a severe complication causing repea… | The Knee 2026-08-13 15:01:34 | Source |
| Primary Soft Tissue Sarcomas of the Extremities: A Nationwide Retrosp… Limb salvage · PMID 42588730 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source : The aim of this study was to determine the oncologic outcomes for adult patients with primary extremity soft tissue s… | Cancers 2026-08-13 15:01:34 | Source |
| Risk of glaucoma among patients using tadalafil for lower urinary tra… Tadalafil · PMID 42552102 | Myopathies | Traitement symptomatique | Publication | PubMed | Voir la publication source To evaluate the association between tadalafil use for lower urinary tract symptoms (LUTS) and the risk of developing gl… | The British journal of ophthalmology 2026-08-13 15:01:34 | Source |
| Multidimensional Factors Influencing the Implementation of Early Mobi… The Impact of Early Mobilization Protocol in Patients in the ICU · PMID 42504084 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source This meta-synthesis of qualitative studies aimed to explore the experiences and perspectives of healthcare providers in… | Journal of advanced nursing 2026-08-13 15:01:28 | Source |
| Stepping it Up on Temporary Mechanical Circulatory Support - Mobiliza… The Impact of Early Mobilization Protocol in Patients in the ICU · PMID 42521141 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Early mobilization and prehabilitation in patients supported with temporary mechanical circulatory support (tMCS) have… | Journal of cardiac failure 2026-08-13 15:01:28 | Source |
| Clinical Impact of Complete Revascularization Before Left Ventricular… Revascularization · PMID 42590810 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Limited information exists regarding whether coronary revascularization by percutaneous coronary intervention (PCI) pri… | Artificial organs 2026-08-13 15:01:25 | Source |
| Postoperative perfusion volume on territorial arterial spin labeling… Revascularization · PMID 42591086 | Myopathies | Traitement symptomatique · Thérapie génique | Publication | PubMed | Voir la publication source Cerebral hyperperfusion syndrome (CHS) after revascularization for moyamoya disease (MMD) represents a failure of cereb… | Frontiers in physiology 2026-08-13 15:01:25 | Source |
| Cohort, gender and spatial patterns of delayed school enrolment in th… COVID-19 Pandemic and Parents of Disabled Children · PMID 42527426 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Delayed school enrolment can be an important marker for developmental delays and be associated with adverse health even… | Scientific reports 2026-08-13 15:01:22 | Source |
| School Readiness, Learning Challenges, and Lifestyle Changes Among Ch… COVID-19 Pandemic and Parents of Disabled Children · PMID 42532839 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source The COVID-19 pandemic disrupted schooling worldwide. While there is evidence of declines in academic performance, the l… | The Journal of school health 2026-08-13 15:01:22 | Source |
| From trunk and hip muscle function to class allocation: understanding… Manual muscular test · PMID 42539762 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Functional assessment in wheelchair basketball (WB) has three evaluation stages: analysis of isolated functions, combin… | Frontiers in sports and active living 2026-08-13 15:01:21 | Source |
| Precision and Error Propagation in Static MEMS-IMU Inertial Navigatio… test of walk · PMID 42590462 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source This paper investigates the precision and stochastic error propagation of navigation solutions obtained from a low-cost… | Sensors (Basel, Switzerland) 2026-08-13 15:01:20 | Source |
| The Effect of Whole-Body Cryotherapy on Exercise Capacity of Healthy… test of walk · PMID 42590172 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source : To analyze the effect of whole-body cryotherapy on exercise tolerance in healthy, training men related to their profe… | Journal of clinical medicine 2026-08-13 15:01:20 | Source |
| A qualitative study on the vulnerability factors of unintentional inj… Awareness Levels of Caregivers of Disabled Children · PMID 42577259 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Unintentional injuries represent a primary cause of child mortality worldwide. However, child injury research in China… | Frontiers in public health 2026-08-13 15:01:19 | Source |
| Intrathecal Baclofen Pump Therapy for Medically Refractory Stiff Pers… baclofen · PMID 42578902 | Myopathies | Immunomodulation · Traitement symptomatique | Publication | PubMed | Voir la publication source This study aimed to describe clinical outcomes, dosing, and safety of intrathecal baclofen (ITB) therapy in patients wi… | Neuromodulation : journal of the International Neuromo… 2026-08-13 15:01:12 | Source |
| On-Demand Hospital Manufacturing of Baclofen Lozenges Using Pharmaceu… baclofen · PMID 42581260 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Dysphagia in neurological patients complicates oral drug administration. Manual preparation of lozenges/troches lacks p… | Pharmaceutical research 2026-08-13 15:01:12 | Source |
| Cytokine Release Syndrome Induced by Neoadjuvant Pembrolizumab in Ear… Prednisolone · PMID 42583655 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Cytokine release syndrome (CRS) is a rare but potentially severe immune-related adverse event associated with immune ch… | Case reports in oncology 2026-08-13 15:00:21 | Source |
Exploration — prudence
Pistes exploratoires 6
Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.
Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| N-PPG N-PPG — modulation métabolique cérébrale | Myopathies | Remyélinisation indirecte / réparation · Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation métabolique et mitohormèse N-PPG est étudié dans Maladie de Huntington et documente plusieurs axes biologiques pouvant être pertinents pour Myopat… | Rapprochement Biomedical Watch · Maladie de Huntington | Détail |
| Vecteur Ple389 (ADORA2A) MiniPromoter Ple389 — ciblage striatal | Myopathies | Thérapie génique | Hypothèse exploratoire | Rapprochement automatique non validé | Expression génique ciblée dans les neurones striataux Vecteur Ple389 (ADORA2A) est étudié dans Maladie de Huntington et documente plusieurs axes biologiques pouvant être per… | Rapprochement Biomedical Watch · Maladie de Huntington | Détail |
| α-Amyrin α-Amyrin — protection mitochondriale | Myopathies | Remyélinisation indirecte / réparation · Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Protection mitochondriale et modulation de la pathologie Tau α-Amyrin est étudié dans Maladie d’Alzheimer et documente plusieurs axes biologiques pouvant être pertinents pour Myopa… | Rapprochement Biomedical Watch · Maladie d’Alzheimer | Détail |
| 4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation | Myopathies | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation immunométabolique de la microglie 4-octyl itaconate et dérivés est étudié dans Sclérose latérale amyotrophique et documente plusieurs axes biologiques po… | Rapprochement Biomedical Watch · Sclérose latérale amy… | Détail |
| Thonningianin A Thonningianin A — neuroprotection anti-amyloïde | Myopathies | Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation du stress oxydatif et des protéines associées à Alzheimer Thonningianin A est étudié dans Maladie d’Alzheimer et documente plusieurs axes biologiques pouvant être pertinents pou… | Rapprochement Biomedical Watch · Maladie d’Alzheimer | Détail |
| Vutiglabridin Vutiglabridin — autophagie et PON2 | Myopathies | Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Activation de PON2 et stimulation de l’autophagie Vutiglabridin est étudié dans Maladie d’Alzheimer et documente plusieurs axes biologiques pouvant être pertinents pour… | Rapprochement Biomedical Watch · Maladie d’Alzheimer | Détail |